 | • レポートコード：QYR2104Z4465 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、患者由来異種移植/PDXモデルのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（マウスモデル、ラットモデル）、用途別市場規模（前臨床医薬品開発＆基礎がん研究、バイオマーカー分析）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・患者由来異種移植/PDXモデルの市場動向 ・企業の競争状況、市場シェア ・患者由来異種移植/PDXモデルの種類別市場規模（マウスモデル、ラットモデル） ・患者由来異種移植/PDXモデルの用途別市場規模（前臨床医薬品開発＆基礎がん研究、バイオマーカー分析） ・患者由来異種移植/PDXモデルの北米市場規模2016-2027（アメリカ、カナダ） ・患者由来異種移植/PDXモデルのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・患者由来異種移植/PDXモデルのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・患者由来異種移植/PDXモデルの中南米市場規模2016-2027（メキシコ、ブラジル） ・患者由来異種移植/PDXモデルの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Crown Bioscience、The Jackson Laboratory、Champions Oncology、Charles River Laboratories、WuXi Apptec、Oncodesign、Horizon Discovery、Pharmatest Services、Hera Biolabs、EPO Berlin-Buch、Xentech、Urolead） ・結論 |
Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient’s tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.
Several types of immunodeficient mice can be used to establish PDX models: athymic nude mice, severely compromised immune deficient (SCID) mice, NOD-SCID mice, and recombination-activating gene 2 (Rag2)-knockout mice. The mice used must be immunocompromised to prevent transplant rejection. The NOD-SCID mouse is considered more immunodeficient than the nude mouse, and therefore is more commonly used for PDX models because the NOD-SCID mouse does not produce natural killer cells.
Market Analysis and Insights: Global Patient Derived Xenograft/PDX Models Market
The global Patient Derived Xenograft/PDX Models market size is projected to reach US$ 163 million by 2026, from US$ 86 million in 2019, at a CAGR of 9.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Patient Derived Xenograft/PDX Models market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Patient Derived Xenograft/PDX Models market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Patient Derived Xenograft/PDX Models market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Patient Derived Xenograft/PDX Models market.
Global Patient Derived Xenograft/PDX Models Scope and Market Size
Patient Derived Xenograft/PDX Models market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Patient Derived Xenograft/PDX Models market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Mice Models
Rat Models
Segment by Application
Pre-clinical Drug Development and Basic Cancer Research
Biomarker Analysis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi Apptec
Oncodesign
Horizon Discovery
Pharmatest Services
Hera Biolabs
Charles River Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mice Models
1.2.3 Rat Models
1.3 Market by Application
1.3.1 Global Patient Derived Xenograft/PDX Models Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pre-clinical Drug Development and Basic Cancer Research
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient Derived Xenograft/PDX Models Market Perspective (2016-2027)
2.2 Patient Derived Xenograft/PDX Models Growth Trends by Regions
2.2.1 Patient Derived Xenograft/PDX Models Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Patient Derived Xenograft/PDX Models Historic Market Share by Regions (2016-2021)
2.2.3 Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2022-2027)
2.3 Patient Derived Xenograft/PDX Models Industry Dynamic
2.3.1 Patient Derived Xenograft/PDX Models Market Trends
2.3.2 Patient Derived Xenograft/PDX Models Market Drivers
2.3.3 Patient Derived Xenograft/PDX Models Market Challenges
2.3.4 Patient Derived Xenograft/PDX Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Derived Xenograft/PDX Models Players by Revenue
3.1.1 Global Top Patient Derived Xenograft/PDX Models Players by Revenue (2016-2021)
3.1.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Players (2016-2021)
3.2 Global Patient Derived Xenograft/PDX Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Patient Derived Xenograft/PDX Models Revenue
3.4 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio
3.4.1 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Derived Xenograft/PDX Models Revenue in 2020
3.5 Patient Derived Xenograft/PDX Models Key Players Head office and Area Served
3.6 Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
3.7 Date of Enter into Patient Derived Xenograft/PDX Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Derived Xenograft/PDX Models Breakdown Data by Type
4.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Type (2016-2021)
4.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Type (2022-2027)
5 Patient Derived Xenograft/PDX Models Breakdown Data by Application
5.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Application (2016-2021)
5.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Patient Derived Xenograft/PDX Models Market Size (2016-2027)
6.2 North America Patient Derived Xenograft/PDX Models Market Size by Type
6.2.1 North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
6.2.2 North America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
6.2.3 North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
6.3 North America Patient Derived Xenograft/PDX Models Market Size by Application
6.3.1 North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
6.3.2 North America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
6.3.3 North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
6.4 North America Patient Derived Xenograft/PDX Models Market Size by Country
6.4.1 North America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
6.4.2 North America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Patient Derived Xenograft/PDX Models Market Size (2016-2027)
7.2 Europe Patient Derived Xenograft/PDX Models Market Size by Type
7.2.1 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
7.2.2 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
7.2.3 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
7.3 Europe Patient Derived Xenograft/PDX Models Market Size by Application
7.3.1 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
7.3.2 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
7.3.3 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
7.4 Europe Patient Derived Xenograft/PDX Models Market Size by Country
7.4.1 Europe Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
7.4.2 Europe Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size (2016-2027)
8.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type
8.2.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
8.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application
8.3.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
8.4 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region
8.4.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Patient Derived Xenograft/PDX Models Market Size (2016-2027)
9.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Type
9.2.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
9.2.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
9.2.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
9.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Application
9.3.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
9.3.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
9.3.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
9.4 Latin America Patient Derived Xenograft/PDX Models Market Size by Country
9.4.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
9.4.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size (2016-2027)
10.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type
10.2.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
10.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application
10.3.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
10.4 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country
10.4.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient Derived Xenograft/PDX Models Introduction
11.1.4 Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.1.5 Crown Bioscience Recent Development
11.2 The Jackson Laboratory
11.2.1 The Jackson Laboratory Company Details
11.2.2 The Jackson Laboratory Business Overview
11.2.3 The Jackson Laboratory Patient Derived Xenograft/PDX Models Introduction
11.2.4 The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.2.5 The Jackson Laboratory Recent Development
11.3 Champions Oncology
11.3.1 Champions Oncology Company Details
11.3.2 Champions Oncology Business Overview
11.3.3 Champions Oncology Patient Derived Xenograft/PDX Models Introduction
11.3.4 Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.3.5 Champions Oncology Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Patient Derived Xenograft/PDX Models Introduction
11.4.4 Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.4.5 Charles River Laboratories Recent Development
11.5 WuXi Apptec
11.5.1 WuXi Apptec Company Details
11.5.2 WuXi Apptec Business Overview
11.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Introduction
11.5.4 WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.5.5 WuXi Apptec Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Details
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient Derived Xenograft/PDX Models Introduction
11.6.4 Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.6.5 Oncodesign Recent Development
11.7 Horizon Discovery
11.7.1 Horizon Discovery Company Details
11.7.2 Horizon Discovery Business Overview
11.7.3 Horizon Discovery Patient Derived Xenograft/PDX Models Introduction
11.7.4 Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.7.5 Horizon Discovery Recent Development
11.8 Pharmatest Services
11.8.1 Pharmatest Services Company Details
11.8.2 Pharmatest Services Business Overview
11.8.3 Pharmatest Services Patient Derived Xenograft/PDX Models Introduction
11.8.4 Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.8.5 Pharmatest Services Recent Development
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Details
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Introduction
11.9.4 Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.9.5 Hera Biolabs Recent Development
11.10 EPO Berlin-Buch
11.10.1 EPO Berlin-Buch Company Details
11.10.2 EPO Berlin-Buch Business Overview
11.10.3 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Introduction
11.10.4 EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.10.5 EPO Berlin-Buch Recent Development
11.11 Xentech
11.11.1 Xentech Company Details
11.11.2 Xentech Business Overview
11.11.3 Xentech Patient Derived Xenograft/PDX Models Introduction
11.11.4 Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.11.5 Xentech Recent Development
11.12 Urolead
11.12.1 Urolead Company Details
11.12.2 Urolead Business Overview
11.12.3 Urolead Patient Derived Xenograft/PDX Models Introduction
11.12.4 Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.12.5 Urolead Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mice Models
Table 3. Key Players of Rat Models
Table 4. Global Patient Derived Xenograft/PDX Models Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Patient Derived Xenograft/PDX Models Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Patient Derived Xenograft/PDX Models Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2016-2021)
Table 8. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2022-2027)
Table 10. Patient Derived Xenograft/PDX Models Market Trends
Table 11. Patient Derived Xenograft/PDX Models Market Drivers
Table 12. Patient Derived Xenograft/PDX Models Market Challenges
Table 13. Patient Derived Xenograft/PDX Models Market Restraints
Table 14. Global Patient Derived Xenograft/PDX Models Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Patient Derived Xenograft/PDX Models Market Share by Players (2016-2021)
Table 16. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2020)
Table 17. Ranking of Global Top Patient Derived Xenograft/PDX Models Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Patient Derived Xenograft/PDX Models Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
Table 21. Date of Enter into Patient Derived Xenograft/PDX Models Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2016-2021)
Table 25. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Patient Derived Xenograft/PDX Models Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2016-2021)
Table 29. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 61. Crown Bioscience Company Details
Table 62. Crown Bioscience Business Overview
Table 63. Crown Bioscience Patient Derived Xenograft/PDX Models Product
Table 64. Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 65. Crown Bioscience Recent Development
Table 66. The Jackson Laboratory Company Details
Table 67. The Jackson Laboratory Business Overview
Table 68. The Jackson Laboratory Patient Derived Xenograft/PDX Models Product
Table 69. The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 70. The Jackson Laboratory Recent Development
Table 71. Champions Oncology Company Details
Table 72. Champions Oncology Business Overview
Table 73. Champions Oncology Patient Derived Xenograft/PDX Models Product
Table 74. Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 75. Champions Oncology Recent Development
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Patient Derived Xenograft/PDX Models Product
Table 79. Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 80. Charles River Laboratories Recent Development
Table 81. WuXi Apptec Company Details
Table 82. WuXi Apptec Business Overview
Table 83. WuXi Apptec Patient Derived Xenograft/PDX Models Product
Table 84. WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 85. WuXi Apptec Recent Development
Table 86. Oncodesign Company Details
Table 87. Oncodesign Business Overview
Table 88. Oncodesign Patient Derived Xenograft/PDX Models Product
Table 89. Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 90. Oncodesign Recent Development
Table 91. Horizon Discovery Company Details
Table 92. Horizon Discovery Business Overview
Table 93. Horizon Discovery Patient Derived Xenograft/PDX Models Product
Table 94. Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 95. Horizon Discovery Recent Development
Table 96. Pharmatest Services Company Details
Table 97. Pharmatest Services Business Overview
Table 98. Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 99. Pharmatest Services Recent Development
Table 100. Hera Biolabs Company Details
Table 101. Hera Biolabs Business Overview
Table 102. Hera Biolabs Patient Derived Xenograft/PDX Models Product
Table 103. Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 104. Hera Biolabs Recent Development
Table 105. EPO Berlin-Buch Company Details
Table 106. EPO Berlin-Buch Business Overview
Table 107. EPO Berlin-Buch Patient Derived Xenograft/PDX Models Product
Table 108. EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 109. EPO Berlin-Buch Recent Development
Table 110. Xentech Company Details
Table 111. Xentech Business Overview
Table 112. Xentech Patient Derived Xenograft/PDX Models Product
Table 113. Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 114. Xentech Recent Development
Table 115. Urolead Company Details
Table 116. Urolead Business Overview
Table 117. Urolead Patient Derived Xenograft/PDX Models Product
Table 118. Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 119. Urolead Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patient Derived Xenograft/PDX Models Market Share by Type: 2020 VS 2027
Figure 2. Mice Models Features
Figure 3. Rat Models Features
Figure 4. Global Patient Derived Xenograft/PDX Models Market Share by Application: 2020 VS 2027
Figure 5. Pre-clinical Drug Development and Basic Cancer Research Case Studies
Figure 6. Biomarker Analysis Case Studies
Figure 7. Patient Derived Xenograft/PDX Models Report Years Considered
Figure 8. Global Patient Derived Xenograft/PDX Models Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Patient Derived Xenograft/PDX Models Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Patient Derived Xenograft/PDX Models Market Share by Regions: 2020 VS 2027
Figure 11. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2022-2027)
Figure 12. Global Patient Derived Xenograft/PDX Models Market Share by Players in 2020
Figure 13. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Patient Derived Xenograft/PDX Models Revenue in 2020
Figure 15. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2016-2021)
Figure 16. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2022-2027)
Figure 17. North America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 19. North America Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 20. North America Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 21. United States Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 25. Europe Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 26. Europe Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 27. Germany Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Region (2016-2027)
Figure 37. China Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 45. Latin America Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 46. Latin America Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 47. Mexico Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 53. Turkey Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Crown Bioscience Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 57. The Jackson Laboratory Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 58. Champions Oncology Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 59. Charles River Laboratories Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 60. WuXi Apptec Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 61. Oncodesign Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 62. Horizon Discovery Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 63. Pharmatest Services Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 64. Hera Biolabs Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 65. EPO Berlin-Buch Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 66. Xentech Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 67. Urolead Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed